Table 2 Profile of the COPD patients in primary and secondary care
From: Type 2 diabetes and COPD: treatment in the right healthcare setting? An observational study
COPD | |||
|---|---|---|---|
Primary care (n = 270) | Secondary care (n = 121) | p-value | |
Sex | |||
Male, n (%) | 130 (48.3) | 55 (45.5) | 0.62 |
Age (mean, range) in years | 67 (38–99) | 67 (40–94) | 0.89 |
Systolic blood pressure (mmHg, mean ± SD) | 133 ± 14.87 | 132 ± 16.50 | 0.62 |
Missing, n | 61 | 37 | |
Inhalation medication | < 0.001 | ||
Yes, n (%) | 195 (75.2) | 109 (90.1) | |
No, n (%) | 71 (26.3) | 12 (9.9) | |
Missing(%) | 4 (1.5) | 0 (0) | |
Spirometry (percentage on FEV1 of predicted, mean ± SD) | 67.39 ± 16.75 | 57.53 ± 19.14 | < 0.001 |
Missing, n | 126 | 37 | |
Smoking | 0.14 | ||
Yes, n (%) | 110 (40.7) | 31 (25.6) | |
No, n (%) | 14 (5.2) | 6 (5.0) | |
In the past, n (%) | 101 (37.4) | 48 (39.7) | |
Missing, n(%) | 45 (16.7) | 36 (29.8) | |
BMI (kg/m2, mean ± SD) | 26.70 ± 5.09 | 27.49 ± 5.52 | 0.30 |
Missing, n | 58 | 62 | |
CCQ (mean ± SD) | 1.15 ± 0.73 | 2.05 ± 0.66 | 0.015 |
Missing, n | 101 | 117 | |
MRC (mean ± SD) | 1.49 ± 1.03 | 2.50 ± 1.29 | 0.001 |
Missing, n | 142 | 107 | |
Frailty | 0.11 | ||
60 years or older (n) | 196 | 92 | |
Yes, n (%) | 115 (58.7) | 68 (73.9) | |
No, n (%) | 34 (17.3) | 11 (12.0) | |
Missing, n | 47 (24.0) | 13 (14.1) | |
Polypharmacy | 0.002 | ||
60 years or older (n) | 196 | 92 | |
Yes, n (%) | 96 (49.0) | 59 (64.1) | |
No, n (%) | 52 (26.5) | 10 (10.9) | |
Missing, n(%) | 48 (24.5) | 23 (25.0) | |
Multimorbidity | |||
Yes, n (%) | 214 (74.3) | 86 (71.1) | 0.22 |
No, n (%) | 46 (16.0) | 26 (21.5) | |
Missing, n(%) | 28 (9.7) | 9 (7.4) | |